This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

DPS Health and Humana Release Issue Brief on Modifiable Risk Factors of Moderate Risk Individuals

Stock quotes in this article: HUM

LOS ANGELES, March 26, 2014 /PRNewswire/ -- Population health management requires payers and providers to manage the healthcare utilization and costs of low, moderate and high-risk cohorts. To provide insight into the moderate risk cohort, DPS Health, a provider of lifestyle and self-management interventions, and Humana Inc. (NYSE: HUM), have produced an issue brief on how to identify and manage moderate risk individuals.

The Moderate Risk Individual: Not Yet Sick Enough to be Very High Cost explains the need to address the moderate risk population and how to pinpoint and manage these individuals with early stage chronic disease and modifiable risk factors.

The DPS Health/Humana issue brief addresses a serious challenge. Moderate risk individuals, who are estimated to be as much as 35 percent of the population, consume healthcare at a rate of four to six times higher than averages seen among lower cost members, according to data from the Centers for Medicare and Medicaid (CMS). As a result, population health managers must zero in on the moderate risk cohort's modifiable risk factors, which include obesity and challenges with self-management, in order to impact conditions such as pre-diabetes/diabetes, sleep apnea, hypertension, metabolic syndrome and hyperlipidemia.

"Modifying the disease trajectories of individuals within the moderate risk cohort will reduce healthcare utilization and impact costs in the short-term," says Neal Kaufman, MD, MPH, founder and Chief Medical Officer, DPS Health. "Over the long-term, taking action against modifiable risk factors will lessen the chances that moderate risk individuals will become part of the costliest, sickest cohort."

The issue brief sites recent data and studies from Humana that define levels of utilization and cost within the moderate risk cohort, approaches to identifying these individuals, and challenges and opportunities in engaging and intervening.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,804.71 -238.19 -1.40%
S&P 500 1,946.16 -26.13 -1.32%
NASDAQ 4,422.0850 -71.3050 -1.59%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs